ArticleOncogene2016

Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53.

X Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.